Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Immunization Products, Ltd.

A joint venture between Immune Response Corporation and Rhone-Poulnec-Rorer to develop vaccines to treat HIV/AIDS.

Search Projects

  • Director, Medical Affairs